Caris Life Sciences, Inc. Common Stock (NASDAQ:CAI) — Market Cap & Net Worth
Market Cap & Net Worth: Caris Life Sciences, Inc. Common Stock (CAI)
Caris Life Sciences, Inc. Common Stock (NASDAQ:CAI) has a market capitalization of $6.79 Billion ($6.79 Billion) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2923 globally and #1042 in its home market, demonstrating a 13.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Caris Life Sciences, Inc. Common Stock's stock price $28.50 by its total outstanding shares 282680695 (282.68 Million). Also see total assets of Caris Life Sciences, Inc. Common Stock for a full breakdown of the balance sheet.
Caris Life Sciences, Inc. Common Stock Market Cap History: 2025 to 2026
Caris Life Sciences, Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $7.63 Billion to $8.06 Billion (0.00% CAGR). Also see how efficiently does Caris Life Sciences, Inc. Common Stock generate cash for how efficiently the company converts equity into cash flow.
Caris Life Sciences, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Caris Life Sciences, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CAI stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
9.39x
Caris Life Sciences, Inc. Common Stock's market cap is 9.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $7.63 Billion | $812.03 Million | -$537.96 Million | 9.39x | N/A |
Competitor Companies of CAI by Market Capitalization
Companies near Caris Life Sciences, Inc. Common Stock in the global market cap rankings as of September 16, 2026. Review tangible equity quality of Caris Life Sciences, Inc. Common Stock to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Caris Life Sciences, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Caris Life Sciences, Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Caris Life Sciences, Inc. Common Stock's market cap moved from $7.63 Billion to $ 8.06 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.06 Billion | +5.63% |
| 2025 | $7.63 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Caris Life Sciences, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.79 Billion USD |
| MoneyControl | $6.79 Billion USD |
| MarketWatch | $6.79 Billion USD |
| marketcap.company | $6.79 Billion USD |
| Reuters | $6.79 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Caris Life Sciences, Inc. Common Stock
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exom… Read more